Iron deficiency in maintenance hemodialysis patients: assessment of diagnosis criteria and of three different iron treatments.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Nephron

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000186246PMID 1902285
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serum ferritin and bone marrow iron in non-dialysis, peritoneal dialysis and hemodialysis patients with chronic renal failure.

  2009cited by this paper
• Microcytic anemia in dialysis patients: reversible marker of aluminum toxicity.

  1987cited by this paper
• Risk of iron overload and 'hemochromatosis allele(s)' in patients on maintenance hemodialysis.

  1987cited by this paper
• Three-year follow-up after withdrawal of iron therapy in uremic patients on regular dialytic treatment

  1986cited by this paper
• Iron and folate metabolism in renal failure.

  1985cited by this paper
• Splenic siderosis and parenteral iron dextran in maintenance haemodialysis patients.

  1984cited by this paper
• Serum ferritin in haemodialysis patients: role of blood transfusions and 'haemochromatosis alleles' HLA A3, B7 and B14.

  1984cited by this paper
• Serum ferritin in patients on maintenance hemodialysis.

  1983cited by this paper
• Evaluation of iron status in patients on chronic hemodialysis: relative usefulness of bone marrow hemosiderin, serum ferritin, transferrin saturation, mean corpuscular volume and red cell protoporphyrin.

  1983cited by this paper
• Interference from renal dialysis patients' specimens in a direct method for serum iron.

  1983cited by this paper
• Failure of serum ferritin levels to predict bone-marrow iron content after intravenous iron-dextran therapy.

  1982cited by this paper
• Regulation of iron therapy by S-ferritin estimations in patients on chronic hemodialysis.

  1981cited by this paper
• Serum ferritin assay and bone-marrow iron stores in patients on maintenance hemodialysis.

  1980cited by this paper
• Intravenous iron dextran in clinical medicine.

  1980cited by this paper
• Serum ferritin concentration in patients receiving maintenance hemodialysis.

  1980cited by this paper
• Therapy of iron deficiency anemia in patients on maintenance dialysis.

  1979cited by this paper
• Iron balance in hemodialysis patients.

  1977cited by this paper
• Serum ferritin level. Determinant of iron requirement in hemodialysis patients.

  1977cited by this paper
• Blood loss during maintenance hemodialysis.

  1974cited by this paper
• Ferritin in the Serum of Normal Subjects and Patients with Iron Deficiency and Iron Overload

  1972cited by this paper

• Nutritional Status of Hemodialysis Patients with End Stage Renal Disease and Selection and Application of Oral Nutritional Support

  2023cites this paper
• Assessment of Iron Profile among Sudanese Patients with Chronic Renal Failure in Shendi Town

  2019cites this paper
• Parenteral versus oral iron therapy for adults and children with chronic kidney disease.

  2019cites this paper
• ANALYSIS OF PRESCRIPTIONS OF IRON PREPARATION IN VARIOUS INDICATIONS TO GYNECOLOGISTS

  2017cites this paper
• Intravenous Fe-Gluconate-Na for Iron-Deficient Patients on

  2016cites this paper
• Impact of European medicines agency recommendations for hypersensitivity reactions on intravenous iron prescription in haemodialysis centres of the Lombardy region

  2016cites this paper
• Anemia in Patients with Chronic Kidney Disease: Current Screening and management Approaches

  2016cites this paper
• Novel iron-containing phosphate binders and anemia treatment in CKD: oral iron intake revisited.

  2016cites this paper
• New Options for Iron Supplementation in Maintenance Hemodialysis Patients.

  2016cites this paper
• The safety of intravenous iron preparations: systematic review and meta-analysis.

  2015cites this paper
• Iron toxicity: relevance for dialysis patients.

  2014cites this paper
• FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia

  2014cites this paper
• Efficacy and Safety of Intravenous Iron Therapy for Functional Iron Deficiency Anemia in Hemodialysis Patients: A Meta-Analysis

  2014cites this paper
• Nutrition and Anemia in End-stage Renal Disease

  2013cites this paper
• Uso da eritropoetina recombinante humana no tratamento da anemia associada à insuficiência renal crônica : estudo de 20 pacientes em hemodíalise

  2013cites this paper
• Chapter 2: Use of iron to treat anemia in CKD

  2012cites this paper
• Parenteral versus oral iron therapy for adults and children with chronic kidney disease.

  2012cites this paper
• KDIGO clinical practice guidelines for bisphosphonate treatment in chronic kidney disease.

  2011cites this paper
• 2008 Japanese Society for Dialysis Therapy: Guidelines for Renal Anemia in Chronic Kidney Disease

  2010cites this paper
• 2008年版 日本透析医学会「慢性腎臓病患者における腎性貧血治療のガイドライン」

  2008cites this paper
• Intravenous Versus Oral Iron Supplementation for the Treatment of Anemia in CKD: An Updated Systematic Review and Meta-analysis.

  2008cites this paper
• Intravenous versus oral iron supplementation for the treatment of anemia in CKD: systematic review and meta-analysis.

  2008cites this paper
• Isolated glycosaminoglycans from cooked haddock enhance nonheme iron uptake by Caco-2 cells.

  2008cites this paper
• Intravenous versus Oral Iron Supplementation in Peritoneal Dialysis Patients

  2007cites this paper
• Nonheme iron absorption in young women is not influenced by purified sulfated and unsulfated glycosaminoglycans.

  2007cites this paper
• Dietary factors influencing non-heme iron absorption

  2007cites this paper
• Iron deficiency in patients with chronic kidney disease: potential role for intravenous iron therapy independent of erythropoietin

  2007cites this paper
• UNIVERSIDADE FEDERAL DE SANTA MARIA

  2006cites this paper
• Iron

  2006cites this paper
• Biochemical Targets

  2006cites this paper
• O ESTRESSE OXIDATIVO EM PACIENTES HEMODIALISADOS E A INFLUÊNCIA DO TRATAMENTO TERAPÊUTICO

  2006cites this paper
• Drug Insight: safety of intravenous iron supplementation with sodium ferric gluconate complex

  2006cites this paper
• The CARI guidelines. Prevention of progression of kidney disease.

  2006cites this paper
• Iron supplementation in renal anemia.

  2006cites this paper
• Low incidence of adverse events following 90-minute and 3-minute infusions of intravenous iron sucrose in children on erythropoietin.

  2005cites this paper
• Low incidence of adverse events following 90‐minute and 3‐minute infusions of intravenous iron sucrose in children on erythropoietin

  2005cites this paper
• Safety and Efficacy of Recombinant Human Eryfhropoietin in Correcting the Anemia of Patients With Chronic Renal Allograft Dysfunction1

  2005cites this paper
• 2004 Japanese Society for Dialysis Therapy Guidelines for Renal Anemia in Chronic Hemodialysis Patients *

  2004cites this paper
• Iron therapy in the pediatric hemodialysis population

  2004cites this paper
• Erythropoietic agents, iron and hemoglobin—What happens beyond the trial setting: Observational data from the ANZDATA Registry

  2004cites this paper
• Management of anemia in patients with chronic kidney disease

  2004cites this paper
• Loss of captopril-bound Fe by end-stage renal failure patients during hemodialysis.

  2004cites this paper
• Ferrlecit ( sodium ferric gluconate complex in sucrose injection )

  2004cites this paper
• Spanish epidemiological study of the anaemia in predialysis patients

  2003cites this paper
• Advances in anaemia management: Current evidence

  2002cites this paper
• Parenteral iron supplementation for the treatment of iron deficiency anemia in children

  2002cites this paper
• Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran.

  2002cites this paper
• Continuous Intravenous Sodium Ferric Gluconate Improves Efficacy in the Maintenance Phase of EPOrHu Administration in Hemodialysis Patients

  2002cites this paper
• IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000.

  2001cites this paper
• The role of iron status markers in predicting response to intravenous iron in haemodialysis patients on maintenance erythropoietin.

  2001cites this paper
• Diagnosis of Iron-Deficiency Anemia in Hemodialyzed Patients through Support Vector Machines Technique

  2001cites this paper
• Diagnostic value of iron indices in hemodialysis patients receiving epoetin.

  2001cites this paper
• Diferencial transferrina-albúmina (DTA) en el estudio del metabolismo férrico

  2001cites this paper
• Considerations for optimal iron use for anemia due to chronic kidney disease.

  2001cites this paper
• Sodium ferric gluconate complex in the treatment of iron deficiency for patients on dialysis.

  2001cites this paper
• Parenteral iron use in the management of anemia in end-stage renal disease patients.

  2000cites this paper
• Iron metabolism in rhEPO-treated hemodialysis patients.

  2000cites this paper
• Is Absorption of High-Dose Oral Iron Sufficient in Peritoneal Dialysis Patients?

  2000cites this paper
• Intravenous iron dextran and erythropoietin use in pediatric hemodialysis patients

  2000cites this paper
• The Comparative Safety of Intravenous Iron Dextran, Iron Saccharate, and Sodium Ferric Gluconate

  2000cites this paper
• Sodium ferric gluconate complex in sucrose is safe and effective in hemodialysis patients: North American Clinical Trial.

  1999cites this paper
• Is there material hazard to treatment with intravenous iron?

  1999cites this paper
• Parenteral Iron Therapy: Safety and Efficacy

  1999cites this paper
• An indistinct balance: the safety and efficacy of parenteral iron therapy.

  1999cites this paper
• Role of iron in optimizing responses of anemic cancer patients to erythropoietin.

  1999cites this paper
• Strategies for iron supplementation: oral versus intravenous.

  1999cites this paper
• Erythropoietin hyporesponsiveness: from iron deficiency to iron overload.

  1999cites this paper
• Intravenous iron for the treatment of predialysis anemia.

  1999cites this paper
• A Consensus on Current Issues and Controversies in Iron Management of Patients with Chronic Renal Failure

  1999cites this paper
• Iron status and iron supplementation in peritoneal dialysis patients.

  1999cites this paper
• Comparative Look at Intravenous Iron Agents: Pharmacology, Efficacy, and Safety of Iron Dextran, Iron Saccharate, and Ferric Gluconate

  1999cites this paper
• Intravenous iron supplementation in end-stage renal disease patients.

  1999cites this paper
• Iron Management in Predialysis Patients

  1999cites this paper
• Iron monitoring and supplementation: how do we achieve the best results?

  1998cites this paper
• Correction of Uremic Iron Deficiency Anemia in Hemodialyzed Patients: A Prospective Study

  1998cites this paper
• Iron supplementation in haemodialysis--practical clinical guidelines.

  1998cites this paper
• Angiotensin-converting enzyme gene polymorphism and antiproteinuric response to renoprotective therapy.

  1998cites this paper
• Experience with i.v. iron chondroitin-sulphate colloid in Japanese haemodialysis patients.

  1998cites this paper
• Effetti Precoci e Tardivi Dell'eritropoietina Sul Metabolismo Glicidico in Pazienti Emodializzati

  1997cites this paper
• Red cell ferritin, a marker of iron deficiency in hemodialysis patients.

  1997cites this paper
• Low serum vitamin B12 levels in chronic high-flux haemodialysis patients.

  1997cites this paper
• Supplementing iron intravenously in pregnancy. A way to avoid blood transfusions.

  1997cites this paper
• Safety Aspects of Parenteral Iron in Patients with End-Stage Renal Disease

  1997cites this paper
• Reticulocyte hemoglobin content in the evaluation of iron status of hemodialysis patients.

  1997cites this paper
• Iron management in end-stage renal disease.

  1997cites this paper
• Intravenous administration of iron gluconate during haemodialysis.

  1997cites this paper
• Achieving target hematocrit in dialysis patients: new concepts in iron management.

  1997cites this paper
• The dilemma of evaluating iron status in dialysis patients--limitations of available diagnostic procedures.

  1997cites this paper
• Erythropoietin and iron.

  1997cites this paper
• Lipid and apolipoprotein patterns during erythropoietin therapy: roles of erythropoietin, route of administration, and diet.

  1997cites this paper
• IN-DEPTH REVIEW Iron Management in End-Stage Renal Disease

  1997cites this paper
• Anémies par carence en fer

  1997cites this paper
• Early and late effects of erythropoietin on glucose metabolism in maintenance hemodialysis patients.

  1996cites this paper
• 'Oversaturation' of transferrin after intravenous ferric gluconate (Ferrlecit(R)) in haemodialysis patients.

  1996cites this paper
• [Single weekly dose of recombinant erythropoietin in children with chronic renal insufficiency].

  1996cites this paper
• Ponto de Vista Histórico. XVIII Congresso Brasileiro de Nefrologia.

  1996cites this paper
• r-HuEPO-economizing effect of saccharated ferric oxide in dialysis patients on r-HuEPO maintenance therapy

  1996cites this paper
• Revisão/Atualização em Diálise: Reposição do ferro em pacientes em tratamento pela eritropoetina humana recombinante

  1996cites this paper
• Safety of intravenous injection of iron saccharate in haemodialysis patients.

  1996cites this paper
• ‘Oversaturation’ of transferrin after intravenous ferric gluconate (FerrlecitR) in haemodialysis patients

  1996cites this paper